** Shares of medical device maker InspireMD NSPR.O rise 10.61% to $1.98

** Co posts Q4 revenue of $3.1 million, above analysts' average estimate of $2.6 million, according to data compiled by LSEG

** Says quarterly revenue rose on early U.S. uptake of CGuard Prime, its neck artery implant to help prevent stroke, and higher international demand for CGuard, its earlier version

** Expects FY26 revenue in the range of $13 million to $15 million vs. analysts' estimate of $14.6 million

** Posts Q4 loss of 14 cents per share, while analysts expected a loss of 19 cents per share

** NSPR shares down ~32% in 2025

(Reporting by Kunal Das in Bengaluru)

((Kunal.Das2@thomsonreuters.com;))